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RESEARCH NOTE
Lipoblastoma: a clinicopathologic review 
of 23 cases from a major tertiary care center 
plus detailed review of literature
Jamshid Abdul‑Ghafar2*, Zubair Ahmad1, Muhammad Usman Tariq1, Naila Kayani1 and Nasir Uddin1
Abstract 
Objective: Lipoblastoma is a rare neoplasm that occurs mostly in infants and children. Although benign, it has a 
tendency for local recurrence.
Results: Clinical and pathological features of 23 cases of lipoblastoma described. Patients’ age ranged from 8 months 
to 18 years with mean and median age 4.1 and 2.5 years, respectively. Male:female ratio was 2.8:1. Most common sites 
were lower extremities (9 cases), followed by abdominal cavity and retroperitoneum (4 cases), and scrotum/groin (3 
cases). Grossly, 22 tumors were well circumscribed and multi nodular. All cases showed lobules composed of adi‑
pocytes and lipoblasts with intervening fibrous septa and fine vascular network. Myxoid change, capsule formation 
and septation were seen in all cases. Zonation was seen in 2 cases. Follow‑up was available in 14 out of 23 patients. 
Of these, 13 were alive and free of disease with no evidence of any recurrent lesion. One patient with a mediastinal 
infiltrating lipoblastoma experienced 4 recurrences. Lipoblastoma is a benign adipocytic neoplasm of infants and 
young children. Correlation of clinical and histological features helps in reaching a correct diagnosis. Owing to a high 
recurrence rate following incomplete resection, a complete resection is essential. Prognosis is excellent after complete 
resection.
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Introduction
Lipoblastomas are rare benign usually encapsulated neo-
plasms of infants and children, more common in males 
with a tendency for local recurrence, first described as 
lipoblastic tumors in infants and children under 3 years 
composed of fetal adipose tissue [1–5].
Local recurrence is common, up to 80%, in incompletely 
resected tumors [6–8]. Complete surgical excision is 
essential to prevent recurrence. Grossly, pale yellow, myx-
oid cut surface with small cystic foci and microscopically, 
lobules composed of immature adipose tissue separated 
by fibrous septa and lipoblasts in different stages are seen 
with no atypia or mitoses, plexiform capillary network 
and mature adipose tissue are seen in the central part 
of the lobules [9]. Lipoblastomas arise from embryonic 
white fat as rapidly enlarging masses. Most common loca-
tions include extremities and trunk [10–15]. Lipoblasto-
mas have been reported in head and neck [12, 13, 16–21], 
mediastinum, axilla, labia, vulva, abdomen, retroperito-
neum, groin, inguinoscrotal, and gluteal region [14–16, 
22–27]. Lipoblastomatosis is reserved for lesions which 
demonstrate infiltrative growth [2, 8, 11, 16, 20, 21].
We report 23 cases and this series is the largest from 
the Indian sub-continent. Our aim was to describe the 
clinicopathological features of lipoblastomas which are 
important in their accurate diagnosis and differentia-
tion from histologically similar neoplasms. The follow up 
information will help us understand their behavior.
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Main text
Materials and methods
We searched the surgical pathology database of the two 
collaborative tertiary care hospitals Aga Khan University 
Hospital, Karachi, Pakistan and French Medical Insti-
tute for Mothers and Children, Kabul, Afghanistan. We 
retrieved 23 cases diagnosed as “Lipoblastoma” between 
2006 and 2016. Inclusion criteria were presence of admix-
ture of adipocytes and lipoblasts, primitive mesenchymal 
cells, plexiform vascular network and fibrous septations. 
Cases in which expression of immunohistochemical 
(IHC) markers (S100, CD34 and Desmin) was incompat-
ible with histological features were excluded. Patients 
above 20  years were not included. Existing co-morbidi-
ties such as congenital heart disease or diabetes mellitus 
led to exclusion. Demographic data including patients’ 
age, gender, presenting complaints, tumor location, 
size and gross appearance was available from pathology 
reports. Hematoxylin and eosin and immunohistochemi-
cal slides were reviewed for microscopic features. We 
looked for zonation, myxoid change, lobulation and IHC 
expression. Slides were stained with CD34 (Ready To Use 
[RTU] Monoclonal antibody, QBEnd 10 clone, Dako), 
S100 (RTU Polyclonal antibody, Dako) and Desmin (RTU 
Monoclonal antibody, D33 clone, Dako). Follow up data 
of patients treated at our two institutions was obtained 
from hospital medical records. Follow up duration was 
defined as the time interval between the date of diagnosis 
and date of last follow up. For patients treated at other 
hospitals, follow up data was obtained from the guard-
ians through interview conducted via telephone. Inter-
view questions were pre-designed and a proforma was 
filled for each case. Follow up data was obtained from 14 
patients. As this was a descriptive cross-sectional study, 
no statistical tests were applied. However, descriptive 
statistics such as mean, standard deviation and median 
for quantitative data and percentages for qualitative data 
were calculated after the data was entered in SPSS ver-
sion 19 software.
Results
Patients’ ages ranged from 8  months to 18  years, mean 
and median age 4.1 and 2.5 years, respectively. 17 (74%) 
were males and 6 (26%) were females (Male:female ratio: 
2.8:1).
All patients presented with progressively enlarging 
painless swelling. Most common locations were lower 
extremities (thigh 6, leg 1, foot 2) abdominal cavity/retro-
peritoneum (n = 4) and scrotum/groin (n = 3) (Table 1).
Grossly, 22 tumors were circumscribed and multinod-
ular (Fig.  1a). One case had infiltrative margins. Tumor 
size ranged from 4.5 to 21  cm (mean, 10.8; median, 
9.2  cm). Histologically, all showed lobules composed 
of adipocytes and lipoblasts separated by fibrous septa. 
A fine vascular network was seen. No nuclear atypia or 
mitoses was seen (Fig.  1b–d). Focal or diffuse myxoid 
change, encapsulation and septation were seen in all 
cases. Lobulation was seen in 19 (82.6%) and zonation in 
2 cases (8.6%) (Fig. 2a, b). 
Immunohistochemically, primitive mesenchymal 
cells were reactive for Desmin; adipocytes and vascular 
endothelial cells demonstrated positivity for CD34; adi-
pocytes were positive for S100 protein (Fig. 2c–e).
Follow-up data was available in 14 patients. 13 patients 
were alive and well with no evidence of recurrence. 
Only patient with recurrence was a 14-year-old female 
with a mediastinal lipoblastoma with infiltrative mar-
gins who had multiple local recurrences at 17, 24, 45 and 
47 months after surgery (Additional file 1: Table S1). The 
remaining 9 patients received treatment at other institu-
tions and their medical records were unavailable.
Discussion
Lipoblastomas are the second commonest pediatric 
adipocytic tumors after lipomas. Magnetic resonance 
imaging is the modality of choice for evaluation of 
tumor extension and planning of excision [11, 15–17, 
19, 26–28]. Majority are 5  cm or less in size. However, 
Table 1 Summary of clinicopathological findings (n = 23)
Serial # Age Gender Tumor size (cm) Tumor site
1 2–5 years Female 13 Retroperitoneum
2 < 2 year Male 12.5 Back
3 2–5 years Male 4.5 Neck
4 2–5 years Male 22 Scrotum
5 2–5 years Male 7 Groin
6 < 2 year Male 15 Axilla
7 6–12 years Male N/A Neck, parotid region
8 2–5 years Male 28 Retroperitoneum
9 < 2 year Male 5.5 Scrotum
10 < 2 year Male 10.5 Abdomen
11 < 2 year Male 7.5 Mesentery
12 6–12 years Male 8.5 Foot
13 6–12 years Female 10 Foot heel
14 6–12 years Male 11 Thigh
15 > 12 years Female 21 Mediastinum
16 > 12 years Male 10 Thigh
17 < 2 year Male 9 Leg
18 < 2 year Male 9 Upper back
19 < 2 year Male 4.5 Thigh
20 < 2 year Male 8 Thigh
21 2–5 years Female 7 Arm
22 2–5 years Female 5 Thigh
23 < 2 year Female 9.5 Thigh
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larger tumors have been reported. Majority of tumors in 
our study were greater than 5 cm in size, mean size was 
10.8 cm. This may be related to late presentation owing 
to poor socio-economic conditions and health facilities. 
Grossly, these are soft, lobulated and yellow, white or 
tan in color. Fat, myxoid nodules or cystic spaces sepa-
rated by fine, white, fibrous septa are seen on cut surface 
[9, 14–17, 19, 21, 22, 24, 27, 29]. All tumors in our study 
were encapsulated, soft and showed fibrous septations. 
Our findings were similar to those reported in various 
published studies. Histologically, characteristic lobular 
architecture is seen with sheets of adipocytes separated 
by fibrovascular septa. The adipocytes demonstrate dif-
ferent stages of maturation from primitive spindle cells 
to vacuolated lipoblasts to mature adipocytes in varying 
proportions. Myxoid areas with primitive mesenchy-
mal cells and plexiform capillary network are seen. The 
lobules show a zonal pattern of maturation with mature 
adipocytes in the center and myxoid areas at the periph-
ery. A greater proportion of mature adipocytes (lipoma-
tous pattern) are an indication of maturation. Variable 
numbers of residual lipoblasts are seen in less mature 
myxoid areas [1, 2, 7, 9, 16, 24, 27]. Our findings were 
similar to those reported in various studies. We did not 
find any association between maturity and increasing age 
of patient nor between maturation and tumor site. In one 
study [16], lobules bordered by septa were seen in 44%, 
prominent blood vessels in 76% and myxoid foci in 52% 
cases. Mitoses are rare, abnormal mitoses are never seen 
[9, 16, 17, 19–21, 23, 29]. On IHC, adipocytes are positive 
for CD34 and S100 protein, while primitive cells are posi-
tive for Desmin [9]. Our findings were in concordance 
with the reported findings.
The genetic hallmark are clonal rearrangements involv-
ing chromosomal region 8q11  >  q13 (8q12). The onco-
gene PLAG1 (pleomorphic adenoma gene 1) is located 
on band 8q12. PLAG1 is activated by a breakpoint in 
the 8q11–13 region or polysomy of chromosome 8 [10, 
11, 23, 25, 28–32]. Molecular analysis is important in the 
accurate diagnosis and optimum management.
The differential diagnoses include pediatric lipoma, 
hibernoma, pediatric myxoid liposarcoma (ML) and well 
differentiated liposarcoma (WDL). Lipoblasts or primi-
tive mesenchymal cells are not seen in lipomas while 
hibernomas are composed of brown fat cells which 
have a central nucleus and abundant finely granular 
Fig. 1 a Gross appearance of lipoblastoma. Tumor is encapsulated and cuut surface is yellow, soft and myxoid. Fibrous septations impart multi‑
nodular imparts appearance. b Microscopic features of of lipoblastoma. Fibrous septations divide the tumor into lobules. c Variable sized multivacu‑
olated lipoblasts (arrows) admixed with adipocytes. d Thin walled branching (plexiform) vasculature
Page 4 of 6Abdul‑Ghafar et al. BMC Res Notes  (2018) 11:42 
cytoplasm. Lipomas are not common in extremities and 
do not show chromosome 8 abnormalities. MLs are very 
rare in children under 10 and are always deeply situated; 
lipoblastomas may be superficial or deep. MLs show 
a characteristic ‘pulmonary edema’ pattern, which is 
attributable to pools of stromal mucin. This is not seen 
in lipoblastomas. MLs may have hypercellular areas while 
lipoblastomas are uniformly hypocellular. MLs show 
nuclear atypia and do not show the lobulated growth 
pattern of lipoblastomas. In MLs, maturation occurs 
towards the periphery while in lipoblastomas, matura-
tion occurs towards the center of the lobules, periphery 
is composed of more primitive cells. MLs do not show 
chromosomal 8 rearrangements. They are characterized 
in 95% cases by recurrent translocation t (12;16) q (13; 
p11) which results in fusion of FUS-DDIT3 genes. It is 
important to differentiate between lipoblastoma and ML 
as the latter are malignant and require aggressive treat-
ment. Immunohistochemically, liposarcomas are MDM2 
and CDK4 positive while lipoblastomas are negative. The 
majority of ML and WDL are positive for p16 while large 
majority of lipoblastomas are negative. A negative p16 
staining may be helpful in excluding liposarcoma in cases 
occurring in adolescence or those with late recurrences 
[33]. Chromosome 8 abnormalities are not seen in WDL.
The treatment of choice is complete surgical resection 
with preservation of vital organs. Prognosis is excellent 
after complete excision even in large tumors. Recurrence 
rates vary from 13 to 46% depending on extent of resec-
tion. Clinical outcome depends on completeness of resec-
tion with a high recurrence rate in incompletely resected 
tumors. Close follow up for minimum of 5  years is rec-
ommended. Various studies have not reported any recur-
rences in completely excised tumors with follow ups of 
Fig. 2 a Lipoblasts and plexiform vasculature is present against myxoid background. b Zonation; primitive mesenchymal cells at the edge of 
fibrous septa merging gradually with adipocytes. c Adipocytes and blood vessels demonstrating positive expression for CD34 IHC stain. d Adipo‑
cytes demonstrating positive expression for S100 IHC stain. e Primitive mesenchymal cells demonstrating positive expression for Desmin IHC stain
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2 months–10 years and median follow up times ranging 
from 38 to 42 months [11, 14, 15, 19, 22, 24, 25, 27, 30].
In our study, 74% patients were males. Male predomi-
nance was noted in multiple studies [1, 2, 5, 6, 8, 24, 
27]. In our series, age range was 8 months–18 years, 11 
(47.8%) patients were younger than 3  years of age, 16 
(69.6%) were 5  years or younger and 19 (82.6%) were 
10 years or younger. In Coffin et al.’s series [1], about 90% 
patients were 10 years or younger. In another series [16], 
84% patients were younger than 5 years. In various stud-
ies [1, 24, 27], ages ranged from 3 months to 16 years.
Most common locations include extremities and trunk 
[10–15]. Ten cases (43.5%) in our study were located in 
the extremities, thigh was the commonest location (26%). 
In one study, 41% were located in the lower extremities 
while 10% were located in the trunk [34]. In another 
study, 44% were located in the extremities [16]. As many 
as 64% cases in one review were located in the trunk [1].
22 cases were discrete with intact capsules. In con-
trast, only 44% tumors reviewed by Collins and Chatten 
[16] were discrete while 56% had irregular margins. Head 
and neck was a common location (16,18). In our series, 2 
(8.6%) cases were located in the head and neck.
All patients presented with progressively enlarging 
painless swelling, the commonest complaint [16, 24, 27] 
seen in up to 92% cases.
Tumor size ranged from 4.5 to 21  cm, mean and 
median size, 10.8 and 9.2 cm, larger compared to average 
reported size (5 cm or less). 16 (69.6%) cases were larger 
than 5 while 10 (43.5%) were larger than 10  cm. In one 
study [16], 60% measured less than 5 cm. Various studies 
reported tumor sizes between 5 and 15 cm [24, 27]. The 
largest reported case measured 26 × 21 cm [35]. Grossly, 
all cases showed lobulated appearance, were soft in con-
sistency and had a yellowish and myxoid cut surface. One 
case had infiltrative margins.
IHC (CD34, S100 protein and Desmin) was performed 
in all cases, often retrospectively when the authors 
reviewed the slides. We recommend routine IHC stain-
ing in all pediatric lipomatous tumors since these help 
in accurate diagnosis especially in cases with equivocal 
morphologic features. Follow up was available in 14 cases 
(Additional file  1: Table S1). Follow up period ranged 
from 1 to 109  months, median time of follow up was 
12 months. Only 1 patient, a 14-year-old girl with a medi-
astinal lipoblastoma developed 4 separate recurrences at 
17, 24, 45 and 47 months and underwent repeated resec-
tions. The remaining 13 were alive and free of disease 
with no recurrences. A number of studies did not report 
any recurrence during follow up periods of 1–2 years [17, 
19], a case of inguinolabial lipoblastoma did not recur 
after 6 years of follow up [22]. A low rate of recurrence 
was reported by Fallon et al. [32]. Two recent studies [24, 
27] reported no recurrences in any of their patients with 
median follow up of 42  months (range 18–84  months) 
and 38 months (range 1.8 months–10 years) respectively.
Complete surgical resection and follow up for mini-
mum of 5 years is essential. It is hoped that this series will 
help in increasing awareness in our region about these 
rare tumors among surgeons and pathologists. Pathol-
ogy departments will be encouraged to develop protocols 
regarding use of various IHC stains in accurate diagnosis 
of pediatric adipocytic neoplasms. Correlation between 
clinical and histological features helps in reaching an 
accurate diagnosis. Confirmation by molecular studies is 
recommended.
Limitations
The main limitation of our study was small sample size 
(23 cases) but it needs to be emphasized that lipoblas-
tomas are rare tumors, these 23 cases comprise all cases 
diagnosed in our two institutions over a 10  year period 
and represent the largest series on these rare tumors 
from this region. Absence of follow up in some cases 
was another limitation and was mainly because in many 
remote regions of both countries, communication facili-
ties are suboptimal.
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